Showing 35,001 results

Filters
PrEP science

Another rare PrEP failure reported in San Francisco

News
9 October 2018
UK health services

New report: HIV and Integrated Care – Can STPs deliver?

Editor's pick
NAT
9 October 2018
New & experimental HIV treatments

Doravirine combination works well as a switch option

News
8 October 2018
Activism & civil society

A Global Health Evangelist Is Shocked To Hear He's A 'Genius'

Editor's pick
NPR
8 October 2018
Money

The Gay Men Who Have Lived for Years With Someone Waiting on Their Death

Editor's pick
The Atlantic
8 October 2018
PrEP

HIV prevention drug PrEP to be evaluated for State funding

Editor's pick
Irish Times
8 October 2018
New & experimental HIV treatments

Dual-antibody combination therapy produces three to seven months of viral suppression without pills

News
8 October 2018
PrEP science

First U.S. Failure of Truvada as PrEP Is Reported at IDWeek

Editor's pick
The Body Pro
7 October 2018
Pregnancy and vertical transmission

HIV stigma blocks efforts to prevent mother-to-child transmission in India

Editor's pick
AVERT
5 October 2018
Changing treatment

Merck’s HIV Therapy DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate) Meets Primary Efficacy Endpoint in Phase 3 DRIVE-SHIFT Study Evaluating Switch to DELSTRIGO from Other Antiretroviral Treatment Regimens

Editor's pick
Merck press release
5 October 2018
Changing treatment

Janssen Reports Switching to SYMTUZA™ Results in Maintained High Virologic Suppression and No Resistance Development up to 96-Weeks in Virologically Suppressed Adults with HIV-1

Editor's pick
Janssen press release
5 October 2018
Child developmental issues

Efavirenz in HIV-positive pregnant women, risk of neurological condition in children

Editor's pick
IDSA press release
5 October 2018
PrEP programmes & uptake

Some gay and bisexual men see PrEP as a 'social problem'

News
5 October 2018
Global health initiatives

EU Civil Society forum criticises the EC Working Document on HIV/AIDS, Tuberculosis and Viral Hepatitis: "Weak Signals of Political Commitment" to tackling the diseases in Europe

Editor's pick
Action for Global Health
4 October 2018
Opportunistic infections

HIV-Positive Patients at Higher Risk of Late Mortality Following Cryptococcal Infection

Editor's pick
Contagionlive.com
4 October 2018
Harm reduction

Opioid Crisis Fuels A Spike In HIV Infections, And Experts Fear There's More To Come

Editor's pick
Huffington Post
4 October 2018
The search for a cure

Vedolizumab could be used to target latent HIV harboring in gut

Editor's pick
Healio
4 October 2018
Heterosexual men

Adolescent girls’ male partners are not all much older, much wealthier ‘sugar daddies’

News
4 October 2018
Access to healthcare

Impatient patients turn to online 'buyers club' for new drugs

Editor's pick
Reuters
3 October 2018
Human rights

My court case could see Jamaica follow India and make gay sex legal

Editor's pick
Gay Star News
3 October 2018
New & experimental HIV treatments

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
3 October 2018
Men who have sex with men (MSM)

Nigeria's hidden HIV crisis

Editor's pick
Devex
3 October 2018
Access to healthcare

Desperate border crossings, as Venezuela runs short of HIV drugs

Editor's pick
Reuters
3 October 2018
Retention & linkage to care

Community ART groups: bringing HIV treatment closer to patient's homes and to communities in conflict

Editor's pick
PLoS Blogs
3 October 2018